Clinical Trials Browser

INDUSTRY × Crizotinib × 30 days × Clear all

NCT06564324 2026-04-13

A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung

NCT03375242 2026-03-30

Safety and Efficacy of Xalkori ROS1

Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05160922 2026-03-30

Crizotinib Continuation Clinical Study

Phase 4 Active not recruiting

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic